Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to inform …

Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide
surveillance of cancer survival by central analysis of population-based registry data, as a …

Background Cancer survival is a key measure of the effectiveness of health-care systems.
EUROCARE—the largest cooperative study of population-based cancer survival in Europe—…

Background Cancer survival varies widely between countries. The CONCORD study provides
survival estimates for 1·9 million adults (aged 15–99 years) diagnosed with a first, primary, …

Time trends in cancer risk have often been summarised by the observation that mortality from
cancers associated with tobacco is increasing rapidly, while mortality from all other cancers …

Every year, more than 2 million women worldwide are diagnosed with breast or cervical
cancer, yet where a woman lives, her socioeconomic status, and agency largely determines …

Limited population‐based cancer registry data available in China until now has hampered
efforts to inform cancer control policy. Following extensive efforts to improve the systematic …

Background The authors consider whether differences in stage at diagnosis could explain the
variation in lung cancer survival between six developed countries in 2004–2007. Methods …

Background Assessment of progress in cancer control at the population level is increasingly
important. Population-based survival trends provide a key insight into the overall …

The risk of cancer associated with a broad range of organ doses was estimated in an
international study of women with cervical cancer. Among 150,000 patients reported to one of 19 …